We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
STAGE I‐II MANTLE CELL LYMPHOMA: CHARACTERISTICS AT DIAGNOSIS, THERAPY USED AND OUTCOME.
- Authors
Cozzarelli, S. Verdesoto; Canelo‐Vilaseca, M.; Verge‐Almuni, J.; Kelleher, N.; Domenech, E. Domingo; Ramos, A. C. Oliveira; Lopez‐Pereira, P.; Mussetti, A.; Blazquez, I.; Esteller, F. Climent; Gomez, C. Aguilera; Marti, M. T. Encuentra; Cia, J. Sancho; Sole, J. Rovira; Teigell, L. Escoda; Ramirez, G. Bustamante; Sierra, L. M. Abenoza; Pérez, M. E. Cabezudo; Montaño, A. Aranda; Pérez, S. Sánchez
- Abstract
Progression Free Survival (PFS) and Overall Survival (OS) were determined by the Kaplan-Meier method, and differences in actuarial survival were analyzed by the log-rank method. B Introduction: b Survival of mantle cell lymphoma (MCL) patients has improved in recent years, although it remains an incurable disease. B Patient and Methods: b From January 2000 to May 2022, 24 patients with Ann-Arbor stage I-II MCL (out of 306 patients) were identified at the centers of the Catalan Institute of Oncology in Spain.
- Subjects
MANTLE cell lymphoma; PROGRESSION-free survival; DIAGNOSIS
- Publication
Hematological Oncology, 2023, Vol 41, p751
- ISSN
0278-0232
- Publication type
Article
- DOI
10.1002/hon.3165_599